LingVo.club
📖+10 XP
🎧+10 XP
+15 XP
New mucosal EV vaccine with inverted HA may protect against many flu strains (Level A1) — Microscopic image depicts a virus.

New mucosal EV vaccine with inverted HA may protect against many flu strainsCEFR A1

8 Apr 2026

Adapted from LaTina Emerson-Georgia State, Futurity CC BY 4.0

Photo by Am, Unsplash

Level A1 – Beginner
2 min
69 words
  • Scientists report a new vaccine for the flu.
  • The vaccine may protect against many flu viruses.
  • It uses tiny particles made by cells.
  • These particles carry a changed flu protein.
  • The vaccine is given through the nose.
  • It protects the breathing passages and body.
  • The vaccine makes antibodies and immune cells.
  • Tests in mice showed good protection.
  • This idea could help in epidemics and pandemics.
  • More research is needed.

Difficult words

  • vaccinemedicine that helps the body fight infection
  • protectkeep someone or something safe from harm
    protects
  • particlea very small piece of matter
    particles
  • proteina natural substance in cells and bodies
  • antibodya protein the body makes to fight germs
    antibodies
  • pandemica disease that spreads to many countries
    pandemics

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Would you take a vaccine through your nose?
  • Have you ever had a flu vaccine?
  • Do you think more research is needed?

Related articles

Africa plans to make more vaccines (Level A1)
1 Aug 2025

Africa plans to make more vaccines

The African Union aims for the continent to make most of its own vaccines by 2040. Africa now produces very few vaccines, and plans include new partnerships, factories and international funding, but experts warn of big challenges.

Marburg outbreak in Kigali, Rwanda (Level A1)
6 Feb 2025

Marburg outbreak in Kigali, Rwanda

In July 2024 Rwanda detected its first Marburg outbreak in Kigali, starting among health workers. Authorities and the WHO led a fast response with genomic tests and treatments; most confirmed cases recovered and the outbreak ended in November.